XDH and Tumor Lysis Syndrome: Patients are at high risk for tumor lysis syndrome and acute renal failure and hence require vigorous hydration, alkaline diuresis, electrolyte monitoring, and allopurinol (xanthine oxidase inhibitor) and/or rasburicase (recombinant urate oxidase) [10].